Inovio Pharma begins phase 1b/2 immuno-oncology trial to evaluate atezolizumab in combo with INO-5401 | PHARMABIZ WISHES ALL ITS READERS & ADVERTISERS A HAPPY & PROSPEROUS DIWALI. THE WEBSITE WILL NOT BE UPDATED ON OCTOBER 19 AND 20 ON ACCOUNT OF DIWALI
       
  Editorial
 DANGER OF ANTIBIOTIC RESISTANCE   
 Wednesday, October 18, 2017 
 According to a recent analysis made by the researchers at Queen Mary University of London and Newcastle University, the sales of antibiotics requiring stringent control is rising much faster than ever in India. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Inovio Pharma begins phase 1b/2 immuno-oncology trial to evaluate atezolizumab in combo with INO-5401
17:00  [IST]Aethlon Medical enters collaboration with iBio to advance large-scale production of Hemopurifier
16:00  [IST]US FDA approves Stryker's cementless Mako Total Knee with Triathlon Tritanium
15:15  [IST]US FDA grants priority review status for Bristol-Myers Squibb’s sBLA for Opdivo to treat patients with resected high-risk advanced melanoma
15:00  [IST]NuVasive gets US FDA expanded clearance for TLX Interbody System used in TLIF procedures
14:20  [IST]US FDA approves Janssen's Stelarato to treat adolescents with moderate to severe plaque psoriasis
more news >>
TOP NEWS
08:00  [IST]Maha FDA issues checklist to pharmacy outlets for self compliance of norms
08:00  [IST]BDC&DA urges Centre to enhance GST composition scheme, to cut levy on cancer, HIV drugs
08:00  [IST]Karnataka drugs control dept to modernise infrastructure, streamline processes
08:00  [IST]OPPI stresses need to create innovation ecosystem for quality healthcare in India
08:00  [IST]Acharya & BM Reddy College of Pharmacy to hold Millennial Pharma Students Congress on Nov 10 & 11
08:00  [IST]Despite UGC recognition, Pharm D students denied seats for Ph D in NIPER
more news >>
YESTERDAY'S NEWS
18:00  [IST]Allergan loses Restasis patent case in US court, company plans to appeal
17:00  [IST]EMA committee recommends marketing approval for Janssen’s Zytiga to treat metastatic hormone-sensitive prostate cancer
16:10  [IST]PM dedicates All India Institute of Ayurveda to the nation on National Ayurveda Day
16:00  [IST]ColonaryConcepts partner Sebela Pharma to initiate phase IIb trial of novel colonoscopy preparation kit
15:00  [IST]Researchers identify new regions of human genome linked to skin color variation in some African populations
14:00  [IST]Experimental Ebola vaccines elicit year-long immune response
more news >>
INTERVIEW  
FDA action plan to beef up drug regulatory system
Maharashtra FDA Commissioner, Dr Pallavi Darade
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Delhi High Court's order to bar lab technicians from certifying medical test reports justifiable?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
IPJPI_150x60en_2017
acssymposium
CPhI-WWW-150x60-stat-v1
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |